伊朗东部Birjand高危人群的流感疫苗接种覆盖率和其他相关因素。

Q2 Medicine
Therapeutic Advances in Vaccines and Immunotherapy Pub Date : 2022-11-26 eCollection Date: 2022-01-01 DOI:10.1177/25151355221140229
Azadeh Ebrahimzadeh, Bita Bijari, Amin Azarnoosh, Fatemeh Shakhs Emampour
{"title":"伊朗东部Birjand高危人群的流感疫苗接种覆盖率和其他相关因素。","authors":"Azadeh Ebrahimzadeh,&nbsp;Bita Bijari,&nbsp;Amin Azarnoosh,&nbsp;Fatemeh Shakhs Emampour","doi":"10.1177/25151355221140229","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and aims: </strong>Influenza is an acute respiratory disease with the highest mortality rate in the high-risk groups. Vaccination is a key public health strategy to prevent influenza in high-risk people. This study aimed to assess the influenza vaccination coverage rate and identify its demographic determinants in patients with end-stage renal disease (ESRD), chronic obstructive pulmonary disease (COPD), and diabetes in Birjand, Eastern Iran.</p><p><strong>Methods: </strong>This cross-sectional study included 400 patients (300 diabetic, 60 dialysis, and 40 COPD patients) from September 2017 to August 2018. Using interview method, we completed a questionnaire containing the patients' demographic characteristics, questions about patients' knowledge and attitude toward influenza vaccination, the influenza vaccination history, and the most common causes for vaccination. The relationship between the type of disease and patients' characteristics (exposure) with vaccination coverage (outcome) was investigated.</p><p><strong>Results: </strong>The mean age of participants was 58.7 ± 11.3 years. Also, 58.8% of the patients received at least one dose of the vaccine and the regular injection rate was 32.8%. The coverage of influenza vaccine in dialysis patients was significantly higher than other patients (<i>p</i> < 0.001). The mean knowledge score was 6.17 ± 2.15 out of maximum 9 scores. There was a positive association between age [<i>p</i> = 0.001, odds ratio (OR) = 1.04] and patients' knowledge (<i>p</i> < 0.001, OR = 1.42) with the vaccination coverage.</p><p><strong>Conclusion: </strong>The coverage of influenza vaccine in high-risk patients in Birjand was low. Hence, it is essential to increase the knowledge of high-risk groups about the importance of influenza vaccination and facilitate their access to vaccines.</p>","PeriodicalId":33285,"journal":{"name":"Therapeutic Advances in Vaccines and Immunotherapy","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/65/2c/10.1177_25151355221140229.PMC9703479.pdf","citationCount":"2","resultStr":"{\"title\":\"Influenza vaccination coverage rates and other related factors in high-risk groups in Birjand, East of Iran.\",\"authors\":\"Azadeh Ebrahimzadeh,&nbsp;Bita Bijari,&nbsp;Amin Azarnoosh,&nbsp;Fatemeh Shakhs Emampour\",\"doi\":\"10.1177/25151355221140229\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background and aims: </strong>Influenza is an acute respiratory disease with the highest mortality rate in the high-risk groups. Vaccination is a key public health strategy to prevent influenza in high-risk people. This study aimed to assess the influenza vaccination coverage rate and identify its demographic determinants in patients with end-stage renal disease (ESRD), chronic obstructive pulmonary disease (COPD), and diabetes in Birjand, Eastern Iran.</p><p><strong>Methods: </strong>This cross-sectional study included 400 patients (300 diabetic, 60 dialysis, and 40 COPD patients) from September 2017 to August 2018. Using interview method, we completed a questionnaire containing the patients' demographic characteristics, questions about patients' knowledge and attitude toward influenza vaccination, the influenza vaccination history, and the most common causes for vaccination. The relationship between the type of disease and patients' characteristics (exposure) with vaccination coverage (outcome) was investigated.</p><p><strong>Results: </strong>The mean age of participants was 58.7 ± 11.3 years. Also, 58.8% of the patients received at least one dose of the vaccine and the regular injection rate was 32.8%. The coverage of influenza vaccine in dialysis patients was significantly higher than other patients (<i>p</i> < 0.001). The mean knowledge score was 6.17 ± 2.15 out of maximum 9 scores. There was a positive association between age [<i>p</i> = 0.001, odds ratio (OR) = 1.04] and patients' knowledge (<i>p</i> < 0.001, OR = 1.42) with the vaccination coverage.</p><p><strong>Conclusion: </strong>The coverage of influenza vaccine in high-risk patients in Birjand was low. Hence, it is essential to increase the knowledge of high-risk groups about the importance of influenza vaccination and facilitate their access to vaccines.</p>\",\"PeriodicalId\":33285,\"journal\":{\"name\":\"Therapeutic Advances in Vaccines and Immunotherapy\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-11-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/65/2c/10.1177_25151355221140229.PMC9703479.pdf\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Therapeutic Advances in Vaccines and Immunotherapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/25151355221140229\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2022/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutic Advances in Vaccines and Immunotherapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/25151355221140229","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 2

摘要

背景和目的:流感是高危人群中死亡率最高的一种急性呼吸道疾病。疫苗接种是在高危人群中预防流感的一项关键公共卫生战略。本研究旨在评估伊朗东部Birjand地区终末期肾病(ESRD)、慢性阻塞性肺疾病(COPD)和糖尿病患者的流感疫苗接种覆盖率,并确定其人口统计学决定因素。方法:本横断面研究纳入了2017年9月至2018年8月的400例患者(300例糖尿病患者,60例透析患者和40例COPD患者)。采用访谈法,对患者的人口学特征、对流感疫苗接种的知识和态度、流感疫苗接种史、最常见的疫苗接种原因进行问卷调查。调查了疾病类型和患者特征(暴露)与疫苗接种覆盖率(结果)之间的关系。结果:参与者平均年龄58.7±11.3岁。此外,58.8%的患者至少接种了一剂疫苗,常规注射率为32.8%。透析患者流感疫苗接种率显著高于其他患者(p p = 0.001,优势比(OR) = 1.04),且患者对流感疫苗的了解程度显著高于其他患者(p p = 0.001, OR = 1.04)。因此,必须提高高危人群对流感疫苗接种重要性的认识,并便利他们获得疫苗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Influenza vaccination coverage rates and other related factors in high-risk groups in Birjand, East of Iran.

Influenza vaccination coverage rates and other related factors in high-risk groups in Birjand, East of Iran.

Influenza vaccination coverage rates and other related factors in high-risk groups in Birjand, East of Iran.

Influenza vaccination coverage rates and other related factors in high-risk groups in Birjand, East of Iran.

Background and aims: Influenza is an acute respiratory disease with the highest mortality rate in the high-risk groups. Vaccination is a key public health strategy to prevent influenza in high-risk people. This study aimed to assess the influenza vaccination coverage rate and identify its demographic determinants in patients with end-stage renal disease (ESRD), chronic obstructive pulmonary disease (COPD), and diabetes in Birjand, Eastern Iran.

Methods: This cross-sectional study included 400 patients (300 diabetic, 60 dialysis, and 40 COPD patients) from September 2017 to August 2018. Using interview method, we completed a questionnaire containing the patients' demographic characteristics, questions about patients' knowledge and attitude toward influenza vaccination, the influenza vaccination history, and the most common causes for vaccination. The relationship between the type of disease and patients' characteristics (exposure) with vaccination coverage (outcome) was investigated.

Results: The mean age of participants was 58.7 ± 11.3 years. Also, 58.8% of the patients received at least one dose of the vaccine and the regular injection rate was 32.8%. The coverage of influenza vaccine in dialysis patients was significantly higher than other patients (p < 0.001). The mean knowledge score was 6.17 ± 2.15 out of maximum 9 scores. There was a positive association between age [p = 0.001, odds ratio (OR) = 1.04] and patients' knowledge (p < 0.001, OR = 1.42) with the vaccination coverage.

Conclusion: The coverage of influenza vaccine in high-risk patients in Birjand was low. Hence, it is essential to increase the knowledge of high-risk groups about the importance of influenza vaccination and facilitate their access to vaccines.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Therapeutic Advances in Vaccines and Immunotherapy
Therapeutic Advances in Vaccines and Immunotherapy Medicine-Pharmacology (medical)
CiteScore
5.10
自引率
0.00%
发文量
15
审稿时长
8 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信